Skip to content
PulseMS
Log inJoin
Research & community

MS research, together.

MS research in plain English. Perspectives from people who understand.

Research evidence filters

Filters apply to reviewed research. Unknown dates and unassessed posts are excluded when a corresponding filter is active.

Reset filters
Topics & sourcesFiltered
Research and community updates, newest first.#FatigueClear filters
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedSubjects not reportedInterventionalPeer-reviewed

Effects of Mixed-Amphetamine Salts on Cognitive Function in MS Model

In a randomized, controlled study of 123 participants with MS over 12 weeks, no significant differences were found in cognitive function as measured by the Symbol Digit Modalities Test (SDMT) between those receiving mixed-amphetamine salts (MAS-XR) and a placebo (p = 0.545). There were significant differences in psychosocial measures for the 20 mg MAS-XR group compared to placebo (p = 0.041).

What this does not proveThe study did not show that MAS-XR is effective for cognitive impairment in MS, and the age mismatch between groups could impact the results.
#CognitiveImpairment#Fatigue#QualityOfLife#SymptomMgmtRelevant to Neurologist, Psychiatrist
View abstract on PubMedPMID 42800227AI summary of a published abstract. Not medical advice.